Live Chat ×
Skip to main content

Independent Study with an Expert: The 2020 WHO Classification of Soft Tissue Tumors: What’s New



Original release date:
October 15, 2020
Access to this course expires on:  April 15, 2021 at 11:59 PM Pacific Time
CME 1.25

Course Description
The 5th edition of the World Health Organization (WHO) Classification of Tumors of Soft Tissue and Bone was published in 2020. The changes in the soft tissue tumor chapter include recently described tumor types; new clinically significant prognostic information for a variety of existing entities; and a plethora of novel genetic alterations, some of practical diagnostic relevance. This presentation highlights the major changes to the soft tissue chapter in the 2020 WHO Classification, as well as the new chapter on undifferentiated small round cell sarcomas, with a focus on updates in diagnostic categories, prognostication, and novel markers. Recent discoveries in molecular genetics are also discussed, particularly those of immediate utility in differential diagnosis, including protein correlates detectable using immunohistochemistry.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • To become familiar with recently described tumor types that have been included in the 2020 WHO Classification of Soft Tissue and Bone Tumors
  • To learn how to apply novel immunohistochemical markers that correlate with molecular genetic alterations for the diagnosis of soft tissue tumors

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Jason L. Hornick, MD, PhD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.